[Lobular invasive breast cancer prognostic factors: About 940 patients]
- PMID: 26482833
- DOI: 10.1016/j.gyobfe.2015.09.007
[Lobular invasive breast cancer prognostic factors: About 940 patients]
Abstract
Objectives: To assess the prognostic factors of T1 and T2 infiltrating lobular breast cancers, and to investigate predictive factors of axillary lymph node involvement.
Methods: This is a retrospective multicentric study, conducted from 1999 to 2008, among 13 french centers. All data concerning patients with breast cancer who underwent a primary surgical treatment including a sentinel lymph node procedure have been collected (tumors was stage T1 or T2). Patients underwent partial or radical mastectomy. Axillary lymph node dissection was done systematically (at the time of sentinel procedure evaluation), or in case of sentinel lymph node involvement. Among all the 8100 patients, 940 cases of lobular infiltrating tumors were extracted. Univariate analysis was done to identify significant prognosis factors, and then a Cox regression was applied. Analysis interested factors that improved disease free survival, overall survival and factors that influenced the chemotherapy indication. Different factors that may be related with lymph node involvement have been tested with univariate than multivariate analysis, to highlight predictive factors of axillary involvement.
Results: Median age was 60 years (27-89). Most of patients had tumours with a size superior to 10mm (n=676, 72%), with a minority of high SBR grade (n=38, 4%), and a majority of positive hormonal status (n = 880, 93, 6%). The median duration of follow-up was 59 months (1-131). Factors significantly associated with decreased disease free survival was histological grade 3 (hazard ratio [HR]: 3,85, IC 1,21-12,21), tumour size superior to 2cm (HR: 2,85, IC: 1,43-5,68) and macrometastatic lymph node status (HR: 3,11, IC: 1,47-6,58). Concerning overall survival, multivariate analysis demonstrated a significant impact of age less than 50 years (HR: 5,2, IC: 1,39-19,49), histological grade 3 (HR: 5,03, IC: 1,19-21,25), tumour size superior to 2cm (HR: 2,53, IC: 1,13-5,69). Analysis concerning macrometastatic lymph node status nearly reached significance (HR: 2,43, IC: 0,99-5,93). There was no detectable effect of chemotherapy regarding disease free survival (odds ratio [OR] 0,8, IC: 0,35-1,80) and overall survival (OR: 0,72, IC: 0,28-1,82). Disease free survival was similar between no axillary invasion (pN0) and isolated tumor cells (pNi+), or micrometastatic lymph nodes (pNmic). There were no difference neither between one or more than one macromatastatic lymph node. But disease free survival was statistically worse for pN1 compared to other lymph node status (pN0, pNi+ or pNmic). Factors associated with lymph node involvement after logistic regression was: age from 51 to 65 years (OR: 2,1, IC 1,45-3,04), age inferior to 50 years (OR 3,2, IC: 2,05-5,03), Tumour size superior to 2cm (OR 4,4, IC: 3,2-6,14), SBR grading 2 (OR 1,9, IC: 1,30-2,90) and SBR grade 3 (OR 3,5, IC: 1,61-7,75).
Conclusion: The analysis of this series of 940 T1 and T2 lobular invasive breast carcinomas offers several information: factors associated with axillary lymph node involvement are age under 65 years, tumor size greater than 20mm, and a SBR grade 2 or 3. The same factors were significantly associated with the OS and DFS. The macrometastatic lymph node involvement has a significant impact on DFS and OS, which is not true for isolated cells and micrometastases, which seem to have the same prognosis as pN0.
Keywords: Carcinomes lobulaires invasifs du sein; Facteurs pronostics; Facteurs prédictifs de l’envahissement axillaire; Lobular carcinoma of the breast; Predictive factors of lymph node involvment; Prognosis factors.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].Bull Cancer. 2008 Jul-Aug;95(7):763-72. doi: 10.1684/bdc.2008.0640. Bull Cancer. 2008. PMID: 18755653 French.
-
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.Eur J Surg Oncol. 2017 Apr;43(4):672-679. doi: 10.1016/j.ejso.2016.12.011. Epub 2017 Jan 16. Eur J Surg Oncol. 2017. PMID: 28139362 Clinical Trial.
-
Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.Asian Pac J Cancer Prev. 2014;15(17):7049-54. doi: 10.7314/apjcp.2014.15.17.7049. Asian Pac J Cancer Prev. 2014. PMID: 25227789
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
-
Assessment of axillary lymph node involvement in small breast cancer: analysis of 893 cases.Clin Breast Cancer. 2001 Apr;2(1):59-65; discussion 66. doi: 10.3816/CBC.2001.n.012. Clin Breast Cancer. 2001. PMID: 11899384 Review.
Cited by
-
Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat.Clin Transl Oncol. 2017 Feb;19(2):211-218. doi: 10.1007/s12094-016-1526-9. Epub 2016 Jun 30. Clin Transl Oncol. 2017. PMID: 27364695
-
Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014.Int J Breast Cancer. 2017;2017:2481021. doi: 10.1155/2017/2481021. Epub 2017 Nov 1. Int J Breast Cancer. 2017. PMID: 29201466 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous